Results 1 to 10 of about 15,547 (147)
MECP2 Insufficiency Attenuates RUNX2-Dependent Osteoblast Differentiation via miR-126-3p/DKK1-Mediated Canonical Wnt Signaling Inhibition in Rett Syndrome. [PDF]
MECP2 insufficiency leads to upregulation of miR‐126‐3p, which in turn enhances the endogenous Wnt antagonist DKK1. DKK1 inhibits the canonical Wnt signaling pathway, thereby impairing RUNX2‐dependent osteoblast differentiation. ABSTRACT Rett syndrome (RTT) is a rare neurodevelopmental disorder caused by loss‐of‐function mutations in the gene encoding ...
Dong S +12 more
europepmc +2 more sources
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
MeCP2 protein, encoded by the MECP2 gene, binds to DNA and affects transcription. Outside of this activity the true range of MeCP2 function is still not entirely clear.
Osman Sharifi, Dag H. Yasui
doaj +1 more source
Loss of MeCP2 causes subtle alteration in dendritic arborization of retinal ganglion cells
Methyl-CpG-binding protein (MeCP2) is highly expressed in neurons. It plays an important role in the development of synapses and the formation of circuits in the central nervous system (CNS).
Wooje Lee +3 more
doaj +1 more source
Drosophila as a model for MECP2 gain of function in neurons. [PDF]
Methyl-CpG-binding protein 2 (MECP2) is a multi-functional regulator of gene expression. In humans loss of MECP2 function causes classic Rett syndrome, but gain of MECP2 function also causes mental retardation.
Fernando Vonhoff +3 more
doaj +1 more source
Rett Syndrome (RTT) is a progressive neurological disorder primarily caused by mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2). The heterozygous female brain consists of mosaic of neurons containing both wildtype MeCP2 (MeCP2+) and ...
Leslie eRietveld +3 more
doaj +1 more source
Motor skill deficit is a common and invalidating symptom of Rett syndrome (RTT), a rare disease almost exclusively affecting girls during the first/second year of life.
Claudia Villani +4 more
doaj +1 more source
Sphingolipid Metabolism Perturbations in Rett Syndrome
Rett syndrome is a severe neurodevelopmental disorder affecting mostly females and is caused by loss-of-function mutations in the MECP2 gene that encoded the methyl-CpG-binding protein 2.
Gerarda Cappuccio +6 more
doaj +1 more source
Risk Factors for Late Diagnosis of Rett Syndrome
Investigators at Emory University, Atlanta, GA; Stony Brook, New York; University of California, San Diego; and other centers determined the type of physician who makes the Rett syndrome (RTT) diagnosis and identified risk factors for delayed diagnosis.
J Gordon Millichap
doaj +1 more source
Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands. [PDF]
Dysfunctions of MeCP2 protein lead to various neurological disorders such as Rett syndrome and Autism. The exact functions of MeCP2 protein is still far from clear. At a molecular level, there exist contradictory data.
Carlos Bueno +3 more
doaj +1 more source
Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies. [PDF]
Methyl CpG binding protein 2 (MeCP2) binds DNA, and has a preference for methylated CpGs and, hence, in cells, it accumulates in heterochromatin. Even though it is expressed ubiquitously MeCP2 is particularly important during neuronal maturation. This is
K Laurence Jost +12 more
doaj +1 more source

